Clinical Research Directory

Inclusion Criteria: * Patients must have been prescribed intranasal naloxone in the past 1 year * Patients and caregivers must be able to understand, read, write, and speak English * Patients must have no clinical evidence of cognitive impairment, as determined by the palliative care provider (Memorial Delirium Assessment Scale score of \>= 7) * Patients must sign an informed consent * Caregivers may sign an informed consent if available during the visit * Caregivers may verbally consent over the phone if not present during the visit * Caregiver must be a friend, significant other or family member * Caregivers must have no evidence of cognitive impairment, as determined based on orientation questions pertaining to the date, day of the week, time, and place Exclusion Criteria: * PATIENT: Emotional or psychosocial distress as identified by the patient's palliative care * PATIENT: Participants with Edmonton Symptom Assessment System (ESAS) anxiety score of \> 6